AI Summary Overt hepatic encephalopathy is present in an estimated 10% to 14% of people when cirrhosis is diagnosed, and it develops at some point in 30% to 40% of people with cirrhosis.
Medically reviewed.
Hepatic encephalopathy (HE) is a decline in brain function caused by the liver's reduced ability to clear toxins, mainly ammonia, from the blood. It is a common complication of cirrhosis and other advanced liver disease, ranging from subtle, easily missed changes in attention to severe confusion or unresponsiveness. Two medications used to treat and prevent HE — lactulose and rifaximin — are covered in detail on their own pages below.
This page explains what hepatic encephalopathy is, what triggers an episode, how severity is graded, and how treatment works alongside lifestyle changes. You can also connect with a liver specialist to discuss whether your care plan needs adjusting.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
HEPATIC ENCEPHALOPATHY OVERVIEW
Hepatic encephalopathy (HE) is a decline in brain function that happens when the liver can't clear toxins — mainly ammonia — from the blood. It ranges from covert HE, subtle attention and reaction-time changes usually missed without formal testing, to overt HE, with confusion, disorientation, and a flapping hand tremor called asterixis. Care for HE typically combines medication with monitoring for the infections, bleeding, constipation, and other triggers that set off episodes.
You can explore the individual therapies used to treat and prevent hepatic encephalopathy below, and learn what triggers episodes and how treatment is monitored over time. Because HE is closely tied to how advanced the underlying liver disease is, connecting with a liver specialist can help you understand your risk and care plan.
Lactulose is a non-absorbable sugar and the first-choice treatment for an episode of overt hepatic encephalopathy. It works in the gut, drawing ammonia out of the bloodstream and removing it through more frequent bowel movements. Dosing is adjusted to produce two to three soft bowel movements a day.
Explore this therapy:
Rifaximin is an antibiotic that works mainly in the gut, reducing ammonia-producing bacteria. It's typically added to lactulose after a second episode of hepatic encephalopathy, and the combination lowers the risk of further episodes and related hospitalizations compared with lactulose alone.
Explore this therapy:
Overt hepatic encephalopathy occurs at some point in an estimated 30% to 40% of people with cirrhosis. Providers consider HE treatment for anyone with confusion, disorientation, or personality changes linked to liver disease, and especially for those who have had a previous episode and need ongoing prevention.
DIET & LIFESTYLE SUPPORT
Hepatic encephalopathy treatment works best when combined with lifestyle changes that protect the gut and brain. Nutrition, hydration, and awareness of common triggers all support the ammonia-lowering effect of medication.
The usual targets for people with HE are 35 to 40 kcal per kg of ideal body weight and 1.2 to 1.5 g of protein per kg per day. Restricting protein was once common practice but is now known to be harmful, since malnutrition itself raises HE risk. Small, frequent meals and a late-evening snack help prevent the muscle breakdown that happens during fasting.
Dehydration can make confusion worse, so steady fluid intake matters. Alcohol should be avoided entirely, since it further impairs the liver's ability to clear toxins from the blood.
Infections, gastrointestinal bleeding, constipation, and new sedating medications are the most common triggers of an HE episode. Treating these underlying causes is often central to resolving an episode and preventing the next one.
A nutrition bar designed for liver health can be a simple, consistent way to help meet daily energy and protein goals alongside medication.
Explore Liver Health Nutrition Bars
SEVERITY AND TRIGGERS
Hepatic encephalopathy is graded by severity, from subtle changes that are easy to miss to a medical emergency. Recognizing your stage and its common triggers helps you and your care team act quickly.
Covert HE (CHE) involves subtle deficits in attention, psychomotor speed, and executive function that don't show up on a standard exam. It requires tests such as the Psychometric Hepatic Encephalopathy Score (PHES) or an EEG to detect, but it predicts a higher risk of progressing to overt HE and of hospitalization.
Overt HE (OHE) is diagnosed clinically, based on mental status and motor function. Signs include disorientation, slurred speech, lethargy, and asterixis, a flapping hand tremor. Severity is commonly described using the West Haven grading system, from Grade I (mild confusion) through Grade IV (coma).
Bacterial infections are found in more than half of patients at the time HE presents, making them the most critical trigger to rule out. Gastrointestinal bleeding, constipation, dehydration, and sedating medications are other common precipitating factors.
Grade III or IV HE is a medical emergency that requires airway protection and often an intensive care unit. Blood ammonia levels alone don't add diagnostic or staging value in chronic liver disease — diagnosis relies on clinical assessment, not a single lab number.
TREATMENT MONITORING
Regular monitoring helps your healthcare provider see how you're responding to lactulose or rifaximin and catch early signs of another episode. Follow-up care may include blood tests, tracking your bowel movements and hydration, and periodic cognitive check-ins.
Liver function tests and other blood work help your provider track how advanced your liver disease is and watch for the infections or kidney changes that can trigger hepatic encephalopathy. Blood ammonia levels alone don't add diagnostic or staging value in chronic liver disease, so diagnosis relies on clinical assessment rather than a single ammonia number.
Lactulose dosing is adjusted to produce two to three soft bowel movements a day. Tracking your bowel habits and fluid intake helps you and your provider fine-tune your dose and catch dehydration, a common HE trigger, early.
Because covert HE doesn't show up on a standard exam, providers may use tools such as the Psychometric Hepatic Encephalopathy Score (PHES) or an EEG to track subtle changes in attention and reaction time over time.
Only a qualified healthcare provider can adjust your treatment plan based on your test results and health history.
COMMON QUESTIONS
Hepatic encephalopathy (HE) is a decline in brain function that happens when the liver can't clear toxins, mainly ammonia, from the blood. It's a complication of cirrhosis and other advanced liver disease, and it can range from subtle attention changes to severe confusion or coma. HE is often treatable and reversible with prompt care. Talk with your liver specialist if you or a caregiver notice changes in memory, sleep, or behavior.
Symptoms range from mild irritability, memory lapses, and disorientation to slowed movement, sleep pattern changes, confusion, and in severe cases, a flapping hand tremor called asterixis or unresponsiveness. Overt HE will occur at some point in an estimated 30% to 40% of people with cirrhosis. If confusion appears suddenly or worsens, seek medical attention promptly rather than waiting to see if it passes.
Lactulose, a non-absorbable sugar, is the first-choice treatment. It lowers ammonia by drawing it into the colon and increasing bowel movements, with dosing adjusted for two to three soft stools a day. Rifaximin (Xifaxan), an antibiotic, is typically added after a second HE episode to reduce ammonia-producing gut bacteria and further lower the risk of recurrence.
The most common triggers are bacterial infections, found in more than half of patients at the time HE presents, along with gastrointestinal bleeding, constipation, dehydration, and new sedating medications. Identifying and treating the specific trigger is often central to resolving an episode.
No. Protein restriction was once common practice but is now known to be harmful, since malnutrition and muscle loss are independent risk factors for HE. The usual target is adequate protein, about 1.2 to 1.5 g per kg of body weight daily, along with sufficient calories, small frequent meals, and a late-evening snack.
Yes, in many cases. Prompt treatment of the episode and its trigger, along with ongoing medication such as lactulose or rifaximin, often reverses symptoms and restores normal mental status. Recurrent or persistent HE that doesn't respond to medical therapy is a sign of advanced liver disease and may prompt evaluation for liver transplantation.
Grade III or IV HE (severe confusion, stupor, or coma on the West Haven scale) is a medical emergency requiring immediate care, often in an intensive care unit for airway protection. Any sudden or severe confusion in someone with liver disease warrants urgent medical attention rather than waiting at home.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
